Wells Fargo’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$35.7M Buy
284,338
+28,947
+11% +$3.64M 0.01% 949
2025
Q1
$28.2M Buy
255,391
+8,812
+4% +$975K 0.01% 1015
2024
Q4
$33.7M Sell
246,579
-13,836
-5% -$1.89M 0.01% 916
2024
Q3
$30M Buy
260,415
+25,446
+11% +$2.93M 0.01% 970
2024
Q2
$32.3M Buy
234,969
+13,155
+6% +$1.81M 0.01% 883
2024
Q1
$30.6M Buy
221,814
+118,786
+115% +$16.4M 0.01% 912
2023
Q4
$13.6M Sell
103,028
-4,493
-4% -$592K ﹤0.01% 1322
2023
Q3
$12.1M Buy
107,521
+4,748
+5% +$534K ﹤0.01% 1338
2023
Q2
$9.69M Buy
102,773
+11,559
+13% +$1.09M ﹤0.01% 1547
2023
Q1
$9.23M Buy
91,214
+969
+1% +$98.1K ﹤0.01% 1572
2022
Q4
$10.8M Buy
90,245
+2,500
+3% +$299K ﹤0.01% 1428
2022
Q3
$9.32M Sell
87,745
-2,334
-3% -$248K ﹤0.01% 1504
2022
Q2
$8.78M Sell
90,079
-13,684
-13% -$1.33M ﹤0.01% 1584
2022
Q1
$9.73M Buy
103,763
+11,495
+12% +$1.08M ﹤0.01% 1779
2021
Q4
$7.86M Sell
92,268
-199,713
-68% -$17M ﹤0.01% 1973
2021
Q3
$28M Sell
291,981
-82,475
-22% -$7.91M 0.01% 1381
2021
Q2
$36.4M Buy
374,456
+70,615
+23% +$6.87M 0.01% 1245
2021
Q1
$29.5M Sell
303,841
-21,408
-7% -$2.08M 0.01% 1333
2020
Q4
$31.2M Buy
325,249
+21,837
+7% +$2.09M 0.01% 1258
2020
Q3
$29.2M Buy
303,412
+22,387
+8% +$2.15M 0.01% 1157
2020
Q2
$34.3M Buy
281,025
+38,758
+16% +$4.73M 0.01% 1045
2020
Q1
$21M Buy
242,267
+19,579
+9% +$1.69M 0.01% 1199
2019
Q4
$23.9M Buy
222,688
+7,041
+3% +$757K 0.01% 1350
2019
Q3
$19.4M Sell
215,647
-19,910
-8% -$1.79M 0.01% 1455
2019
Q2
$19.9M Sell
235,557
-321,079
-58% -$27.1M 0.01% 1472
2019
Q1
$49M Sell
556,636
-152,179
-21% -$13.4M 0.01% 902
2018
Q4
$50.6M Sell
708,815
-326,254
-32% -$23.3M 0.02% 815
2018
Q3
$127M Sell
1,035,069
-24,977
-2% -$3.07M 0.04% 496
2018
Q2
$104M Buy
1,060,046
+104,738
+11% +$10.3M 0.03% 559
2018
Q1
$79.2M Sell
955,308
-10,141
-1% -$841K 0.02% 673
2017
Q4
$74.9M Buy
965,449
+20,081
+2% +$1.56M 0.02% 703
2017
Q3
$57.9M Buy
945,368
+119,383
+14% +$7.32M 0.02% 796
2017
Q2
$38M Buy
825,985
+528,863
+178% +$24.3M 0.01% 1003
2017
Q1
$12.9M Buy
297,122
+175,292
+144% +$7.59M ﹤0.01% 1694
2016
Q4
$4.72M Buy
121,830
+63,931
+110% +$2.47M ﹤0.01% 2436
2016
Q3
$2.93M Buy
57,899
+7,792
+16% +$395K ﹤0.01% 2642
2016
Q2
$2.28M Sell
50,107
-18,487
-27% -$840K ﹤0.01% 2849
2016
Q1
$2.71M Sell
68,594
-11,106
-14% -$439K ﹤0.01% 2685
2015
Q4
$4.51M Sell
79,700
-6,139
-7% -$347K ﹤0.01% 2383
2015
Q3
$3.42M Sell
85,839
-23,552
-22% -$937K ﹤0.01% 2560
2015
Q2
$5.23M Buy
109,391
+8,771
+9% +$419K ﹤0.01% 2371
2015
Q1
$4M Buy
100,620
+19,257
+24% +$765K ﹤0.01% 2530
2014
Q4
$1.82M Sell
81,363
-16,963
-17% -$379K ﹤0.01% 3048
2014
Q3
$1.54M Buy
98,326
+13,589
+16% +$213K ﹤0.01% 3139
2014
Q2
$1.26M Buy
84,737
+13,428
+19% +$199K ﹤0.01% 3327
2014
Q1
$1.15M Buy
71,309
+71,208
+70,503% +$1.15M ﹤0.01% 3372
2013
Q4
$1K Hold
101
﹤0.01% 5413
2013
Q3
$1K Sell
101
-1,000
-91% -$9.9K ﹤0.01% 5365
2013
Q2
$15K Buy
+1,101
New +$15K ﹤0.01% 4853